Company page

Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. (OCUL) is a public company based in the United States, specializing in developing innovative therapies for eye diseases. With a market capitalization of approximately $2.06 billion, the company focuses on advancing its pipeline of ophthalmic products. Ocular Therapeutix aims to improve patient outcomes through its proprietary drug delivery technologies.